Mauriello

Novavax Technical and Fundamental Analysis

NASDAQ:NVAX   NOVAVAX INC
Technical Analysis - Check/wait if one of the supports will not be broken before buying
On a daily chart there might be a Bottom Saucer or Rounding Reversal Pattern

Fundamental News:
Novavax (NASDAQ:NVAX) is a clinical-stage biotechnology company focused on the discovery , development and commercialisation of vaccines and adjuvants. Through its recombinant nanoparticle vaccine technology, it produces vaccine candidates to respond to both known and newly emerging diseases.
Novavax topped Wall Street expectations for the first quarter when it reported a loss of 58 cents per share on revenue of $3.4 million earlier this month. Analysts were expecting a loss of 69 cents per share and revenue of $1.9 million.

More importantly, the biotech company announced in its earnings release that the Oslo-based nonprofit Coalition for Epidemic Preparedness Innovations will invest $384 million to advance the clinical development of its SARS-CoV-2 vaccine candidate, NVX-CoV2373.

Novavax plans to start human trials in May with preliminary results expected in July.

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out